Work

POS-079 14-3-3ζ：A PROTECTOR IN CISPLATIN-INDUCED ACUTE KIDNEY INJURY

Year: 2022

Type: conference-abstract

Abstract: Cisplatin is an anticancer agent marred by acute kidney injury (AKI). Limiting this adverse effect may allow the use of higher doses to improve its efficacy. Basing on our previous study verifying that exosomes from bone marrow mesenchymal stem cells (BMSCs) can promote the repair in cisplatin-induced AKI(AKI), the objective of this study was to identify a candidate that targets to alleviate CKI.

Source: Kidney International Reports

DOI: 10.1016/j.ekir.2022.01.088

Authors: Z. SUN, Q. Cai, S. Guo, H. Wu, M. Bao, X. Ding, X. Yu

Institution: Fudan University

Language: English

Topic: Chemotherapy-induced organ toxicity mitigation

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,625

OpenAlex ID: W4212786847

Cites:

Cited by:

Related to: 10